Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2
Launched by ALCON RESEARCH · Aug 24, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Subjects are expected to attend 3 study visits and wear the PRECISION1 and Clariti 1-Day study lenses in a crossover design for approximately 8 days of exposure to each study lens type. The expected duration of subject participation is up to 22 days.
Gender
ALL
Eligibility criteria
- • Key Inclusion Criteria
- • Subject must be able to understand and must sign an Institution Review Board (IRB) approved Informed Consent Form.
- • Successful wear of soft contact lenses in both eyes for a minimum of 5 days per week and 10 hours per day during the past 3 months.
- • Willing to wear contact lenses for at least 16 hours per day on one of the days with each lens type.
- • Other protocol-specified inclusion criteria may apply.
- Key Exclusion Criteria:
- • Any ocular condition that contraindicates contact lens wear.
- • Previous or current habitual wearer of PRECISION1, Clariti 1-Day, or DAILIES TOTAL1 contact lenses.
- • Other protocol-specified exclusion criteria may apply.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maitland, Florida, United States
Powell, Ohio, United States
Medina, Minnesota, United States
Wichita Falls, Texas, United States
Patients applied
Trial Officials
CDMA Project Lead, Vision Care
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials